IYUZEH Drug Patent Profile
✉ Email this page to a colleague
When do Iyuzeh patents expire, and what generic alternatives are available?
Iyuzeh is a drug marketed by Thea Pharma and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-four patent family members in twenty-seven countries.
The generic ingredient in IYUZEH is latanoprost. There are twenty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Iyuzeh
A generic version of IYUZEH was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.
Summary for IYUZEH
International Patents: | 34 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 6,239 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for IYUZEH |
What excipients (inactive ingredients) are in IYUZEH? | IYUZEH excipients list |
DailyMed Link: | IYUZEH at DailyMed |
Pharmacology for IYUZEH
Drug Class | Prostaglandin Analog |
Anatomical Therapeutic Chemical (ATC) Classes for IYUZEH
US Patents and Regulatory Information for IYUZEH
IYUZEH is protected by one US patents.
Patents protecting IYUZEH
Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TOPICAL TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thea Pharma | IYUZEH | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 216472-001 | Dec 13, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for IYUZEH
See the table below for patents covering IYUZEH around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Morocco | 34324 | SYSTEME DE DELIVRANCE POLYMERIQUE D'UNE SOLUTION NON VISQUEUSE A BASE DE PROSTAGLANDINE SANS CONSERVATEUR | ⤷ Try a Trial |
Brazil | 112012033435 | solução oftálmica e frasco de dose única ou multi-dose feito de pebd sem aditivos. | ⤷ Try a Trial |
Singapore | 186361 | POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION | ⤷ Try a Trial |
Mexico | 2012014503 | SISTEMA POLIMERICO PARA SUMINISTRAR UNA SOLUCION NO VISCOSA A BASE DE PROSTAGLANDINA, SIN CONSERVADORES. (POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE-FREE PROSTAGLANDIN-BASED NONVISCOUS SOLUTION.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IYUZEH
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0364417 | 9690031-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST |
3461484 | 301101 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN NETARSUDILMESYLAAT; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
0364417 | 97C0128 | France | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718 |
3461484 | 2021C/515 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ROCLANDA - LATANOPROST / NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/20/1502 20210108 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |